YAP1 and pancreatic neoplasm: More interestingly, Gujral et al. recently showed that nuclear YAP enhanced gemcitabine intracellular availability in multiple human pancreatic cancer cells and tumors by downregulating the expression of multidrug transporters [131], supporting that YAP activation could also contribute to overcoming drug resistance in pancreatic cancer.